• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CONQUEST; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CONQUEST; PTA BALLOON DILATATION CATHETER Back to Search Results
Catalog Number CQ75104
Medical Device Problem Codes Material Rupture (1546); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/18/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiry date: 12/2025) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during a left upper limb venous balloon dilation angioplasty procedure, the pta balloon was allegedly ruptured.The procedure was completed by using another device.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one conquest pta dilatation catheter was returned for evaluation.And during visual analysis fiber disturbance could be noted in the balloon nearer to the distal tip.No specific anomalies were noted to the luers, bifurcate or glue fillets and in returned device.On functional testing the balloon was inflated with an in-house presto inflation device.During inflation water leak could be identified from the balloon.Further, the balloon fibers were stripped and under microscopic observations, a pinhole rupture was noted in the balloon near to the distal tip.No other functional testing was performed.Hence based on the visual analysis of the returned sample, investigation was confirmed for identified fiber disturbance in the balloon near to the distal tip.Based on the microscopic observation, a pinhole balloon rupture was noted.Therefore, the investigation was confirmed for the reported balloon rupture.A definitive root cause for the reported balloon rupture and identified fiber disturbance issue could not be determined based upon the provided information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiry date: 12/2025), g3, h6 (device).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during a left upper limb venous balloon dilation angioplasty procedure, the pta balloon was allegedly ruptured.The procedure was completed by using another device.There was no reported patient injury.
 
Event or Problem Description
It was reported that during a left upper limb venous balloon dilation angioplasty procedure, the pta balloon was allegedly ruptured.The procedure was completed by using another device.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: our firm received an fda email correspondence on 8-july-2024 from mdr data systems team, (b)(6), indicating that the information (specifically the unique device identifier (udi) information in section d) of the previously submitted fda form 3500a, was incorrect and a request was made to submit supplemental report(s) with the entire udi number including the di and pi fields, all numbers, letters, parentheses, and symbols in the ¿unique device identifier (udi) #¿ fields.This supplemental report is in response to that request.H11: d4: medical device expiration date- 12/31/2025.D4: udi - (b)(4).H4: device manufacture date- 02/21/2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONQUEST
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18333523
Report Number2020394-2023-01261
Device Sequence Number6703231
Product Code DQY
UDI-Device Identifier00801741063220
UDI-Public(01)00801741063220(11)230221(17)251231(10)REHN3556
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K083657
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2025
Device Catalogue NumberCQ75104
Device Lot NumberREHN3556
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/04/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/18/2023
Supplement Date Received by Manufacturer02/09/2024
07/08/2024
Initial Report FDA Received Date12/15/2023
Supplement Report FDA Received Date02/20/2024
07/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age56 YR
Patient SexUnknown
-
-